BD announces the first pharmaceutical-sponsored clinical trial using BD Libertas™ handheld injector technology for biologic drugs
July 30, 2025
Biotech Newswire / BD (Becton, Dickinson and Company), a global leader in medical technology, announces the first pharmaceutical-sponsored combination product clinical trial utilizing the BD Libertas™ Wearable Injector for the subcutaneous delivery of complex biologic drugs. The combination product clinical trial, ...
New lines DuPont™ Liveo™ Healthcare Solutions
January 18, 2022
DuPont's new products include: • Liveo™ Pharma TPE Tubing: a range of extruded thermoplastic elastomer (TPE) pharmaceutical tubing dedicated to fluid transport and single-use bioprocessing applications, produced under similar high-quality and purity principles as DuPont's pharmaceutical tubing.
CPhI predictions for 2022
January 10, 2022
CPhI Worldwide publishes its 2022 pharmaceutical market predictions, combining research from more than 350 pharmaceutical executives and expert opinions from 10 CPhI contributors. The findings suggest there will be more than 30 new drug approvals by the FDA in the next year, more than five COVID-XNUMX vaccines, and more than XNUMX new vaccines.
DuPont partners with partners for medical devices
January 3, 2022
DuPont has partnered with TNO Holst Center and Pronat Medical, who designed and produced the Nighthawk™ wearable adhesive patch. The patch concept combines DuPont's material solutions for the medical device market, utilizing Intexar™ stretchable materials, including thermoplastic polyurethane (TPU) films and inks.
